LTRN · Lantern Pharma Inc.
$2.65
+0.14 (+5.58%)
At close · Jul 30
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the existence of substantial doubt regarding our ability to continue as a going concern in the absence of obtaining substantial additional funding”View the 10-Q filed May 15, 2026
Market Cap
$28.37M
Shares
11.30M
Lantern Pharma Inc. Earnings Call Transcripts
Every quarterly earnings call for Lantern Pharma Inc. (LTRN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY25 · Q4
2026-03-30
Lantern Pharma Inc. Q4 FY2025 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-13
Lantern Pharma Inc. Q3 FY2025 Earnings Call
Confident tone
LP-184 Phase Ia Clinical Results
LP-284 Non-Hodgkin's Lymphoma Program
Pipeline Expansion and Indications
Diluted EPS
$-0.39
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-13
Lantern Pharma Inc. Q2 FY2025 Earnings Call
Diluted EPS
$-0.40
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-15
Lantern Pharma Inc. Q1 FY2025 Earnings Call
Confident tone
Clinical pipeline progress
AI platform (RADR) commercialization
HARMONIC trial geographic expansion (Asia)
Diluted EPS
$-0.42
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Lantern Pharma Inc. Q4 FY2024 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-07
Lantern Pharma Inc. Q3 FY2024 Earnings Call
Confident tone
LP-184 / LP-284 synthetic lethal programs
Starlight Therapeutics / CNS oncology (GBM)
LP-300 / Harmonic trial in never-smoker NSCLC
Diluted EPS
$-0.42
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Lantern Pharma Inc. Q2 FY2024 Earnings Call
Diluted EPS
$-0.46
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-29
Lantern Pharma Inc. Q1 FY2024 Earnings Call
Confident tone
Starlight subsidiary and STAR-001 in brain cancer
LP-184 clinical progress in DDR-deficient tumors
AI platform RADR and computational drug discovery
Diluted EPS
$-0.51
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-20
Lantern Pharma Inc. Q4 FY2023 Earnings Call
Confident tone
Clinical Pipeline Progress
AI Platform RADAR
Starlight Therapeutics / CNS Cancers
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-08
Lantern Pharma Inc. Q3 FY2023 Earnings Call
Diluted EPS
$-0.29
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Lantern Pharma Inc. Q2 FY2023 Earnings Call
Diluted EPS
$-0.44
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Lantern Pharma Inc. Q1 FY2023 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-20
Lantern Pharma Inc. Q4 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-07
Lantern Pharma Inc. Q3 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Lantern Pharma Inc. Q2 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-03
Lantern Pharma Inc. Q1 FY2022 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Lantern Pharma Inc. Q4 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-01
Lantern Pharma Inc. Q3 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-29
Lantern Pharma Inc. Q2 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Lantern Pharma Inc. Q1 FY2021 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-10
Lantern Pharma Inc. Q4 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-10-29
Lantern Pharma Inc. Q3 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-24
Lantern Pharma Inc. Q2 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–23 of 23 earnings calls